[On the pharmacology of the new psychoactive drug 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (Ro5-4556)].
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001552:Benzazepines / Q000494:pharmacology* / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D003864:Depression, Chemical; D004064:Digestive System / Q000187:drug effects; D004357:Drug Synergism; D004558:Electric Stimulation; D004569:Electroencephalography; D004702:Endocrine Glands / Q000187:drug effects; D000882:Haplorhini; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009132:Muscles / Q000494:pharmacology*; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013268:Stimulation, Chemical; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000700:Analgesics; D000927:Anticonvulsants; D001552:Benzazepines; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents
Zur Pharmakologie des neuen Psychopharmakons 7-Chlor-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepin (Ro 5-4556)